Welcure Drugs has announced the approval of a bonus issue and a stock split, signaling a strategic move to enhance liquidity and shareholder value. The board has decided to issue bonus shares to existing shareholders while splitting the face value of the stock, making it more affordable for retail investors. These corporate actions aim to improve market participation, broaden the shareholder base, and increase trading activity. Analysts view the move as a positive signal of the company’s robust financial position and confidence in future growth prospects.